Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sintilimab and Anlotinib in Combination With Chemotherapy”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Testing effectiveness (Phase 2)UnknownNCT04124731
What this trial is testing

Combination Therapy of Sintilimab and Anlotinib as a First-line Treatment in Advanced NSCLC (SUNRISE)

Who this might be right for
CarcinomaNon-small Cell Lung Cancer
Shanghai Chest Hospital 98
Testing effectiveness (Phase 2)UnknownNCT04846452
What this trial is testing

Sintilimab, Anlotinib Hydrochloride and Platinum-Containing Dual-Agent Chemotherapy in NSCLC

Who this might be right for
Metastatic NSCLCRecurrent NSCLCAdvanced Non-Small Cell Squamous Lung Cancer
The First Affiliated Hospital with Nanjing Medical University 40
Testing effectiveness (Phase 2)UnknownNCT04004572
What this trial is testing

Sintilimab, Pegaspargase and Anlotinib for Stage IV Natural Killer /T-cell Lymphoma

Who this might be right for
Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
Rong Tao 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT05400070
What this trial is testing

Neoadjuvant PD-1 Inhibitor (Sintilimab), Anlotinib Combined With Chemotherapy in Resectable Stage IIA-IIIB NSCLC

Who this might be right for
SintilimabLung CancerAnlotinib+1 more
Tang-Du Hospital 45
Testing effectiveness (Phase 2)Looking for participantsNCT05188859
What this trial is testing

First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma

Who this might be right for
Mesothelioma, MalignantMesothelioma, Malignant PleuralMesothelioma Malignant Advanced
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 29
Testing effectiveness (Phase 2)Study completedNCT06015035
What this trial is testing

Sintilimab and Anlotinib Combined With Chemotherapy in Neoadjuvant Treatment of Resectable Esophageal Cancer

Who this might be right for
Sintilimab and Anlotinib in Combination With Chemotherapy
Tang-Du Hospital 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT04877821
What this trial is testing

The Efficacy and Safety of Sintilimab Plus Anlotinib Combined With Chemotherapy as Neoadjuvant Therapy in TNBC

Who this might be right for
Triple Negative Breast Cancer
Guangdong Provincial People's Hospital 31